JIPOAd
JIPOAd
PARP
ESID
  • Users Online: 199
  • Print this page
  • Email this page
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
  Access statistics : Table of Contents
   2019| April-June  | Volume 2 | Issue 2  
    Online since April 10, 2019

 
 
  Archives   Previous Issue   Next Issue   Most popular articles   Most cited articles
 
Show all abstracts  Show selected abstracts  Export selected to
  Viewed PDF Cited
REVIEW ARTICLES
Tackling immunotherapy resistance: Developing rational combinations of immunotherapy and targeted drugs
Elena Cojocaru, Mariana Scaranti, Anna Minchom
April-June 2019, 2(2):23-35
DOI:10.4103/JIPO.JIPO_24_18  
  1,311 379 -
Should we design clinical trials differently in the era of cancer immunotherapy?
Chia-Chi Lin
April-June 2019, 2(2):36-39
DOI:10.4103/JIPO.JIPO_5_19  
  1,283 169 1
EDITORIAL
Moonshot for precision medicine
Jordi Rodon
April-June 2019, 2(2):21-22
DOI:10.4103/JIPO.JIPO_4_19  
  1,244 160 -
CASE REPORT
Vedolizumab Achieved Clinical and Histologic Remission in a Patient with Lung Cancer Who Had a Steroid-Refractory Upper Gastrointestinal Injury Due to Nivolumab Treatment
Cynthia Nguyen Tran, Hamzah Abu-Sbeih, Wenyi Luo, Yang Lu, Yinghong Wang
April-June 2019, 2(2):40-45
DOI:10.4103/JIPO.JIPO_18_18  
  1,039 178 -
SPECIAL ARTICLE
5th Annual immuno-oncology 360° conference: Spanning science and business to bring new therapies to patients
Marie Recine
April-June 2019, 2(2):46-51
DOI:10.4103/JIPO.JIPO_6_19  
  1,023 129 -